Article Details
Retrieved on: 2024-08-13 14:23:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. owned approximately 7.86% of Amylyx Pharmaceuticals worth $15,189,000 at the end of the most recent quarter. Get Amylyx ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here